Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (921-930 of 1,052) with videos related to

Pageof 106
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS ReportSmita Bhatia, Chen Dai, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantationFrédéric Baron, Rainer Storb, Barry E Storer, et al.
Leukemia|December 22, 1999
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionD S Snyder, A P Nademanee, M R O'Donnell, et al.
Cancer Cell|July 12, 2017
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell LymphomaYing Gu, Jiawei Zhang, Xiaoxiao Ma, et al.
JAMA Cardiology|November 8, 2023
Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell TransplantJune-Wha Rhee, Raju Pillai, Tianhui He, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
JAMA Oncology|September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myelomaFiroozeh Sahebi, Paul H Frankel, Len Farol, et al.
Communications Biology|March 21, 2023
Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasmsAdeleh Taghi Khani, Anil Kumar, Ashly Sanchez Ortiz, et al.
Pageof 106

Showing results (921-930 of 1,052) with videos related to

Sort By:
Pageof 106
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS ReportSmita Bhatia, Chen Dai, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantationFrédéric Baron, Rainer Storb, Barry E Storer, et al.
Leukemia|December 22, 1999
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionD S Snyder, A P Nademanee, M R O'Donnell, et al.
Cancer Cell|July 12, 2017
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell LymphomaYing Gu, Jiawei Zhang, Xiaoxiao Ma, et al.
JAMA Cardiology|November 8, 2023
Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell TransplantJune-Wha Rhee, Raju Pillai, Tianhui He, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
JAMA Oncology|September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphomaK A Margolin, K Van Besien, C Wright, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myelomaFiroozeh Sahebi, Paul H Frankel, Len Farol, et al.
Communications Biology|March 21, 2023
Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasmsAdeleh Taghi Khani, Anil Kumar, Ashly Sanchez Ortiz, et al.
Pageof 106